Security key
03969F109
Arcus Biosciences, Inc. - Common Stock (RCUS)
CUSIP: 03969F109
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 99,735,332
- Total 13F value
- $811,386,525
- Share change
- +2,523,502
- Put/Call ratio
- 5.2%
- SEC-reported price per share
- $8.14
- Number of holders
- 181
- Value change
- +$23,005,595
- Number of buys
- 107
- Number of sells
- 75
- Shares outstanding
- 122,470,452
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
181
Top holders
10
RCUS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Arcus Biosciences, Inc. SEC filings
Arcus Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03969F109
Recent filing periods:
Ownership snapshot
Top reported holders of RCUS - Arcus Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GILEAD SCIENCES, INC.
Disclosed value leader
GILEAD SCIENCES, INC.
Comparable rows
15/15
Latest evidence
31 Mar 2025
3/4/5
13F
Lead comparable stake: 26%
Showing 1-6 of 15 holder rows.
Quick read
GILEAD SCIENCES, INC. leads the comparable SEC ownership view at 26%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GILEAD SCIENCES, INC.'s linked filing trail.
Comparable ownership
Top 5
GILEAD SCIENCES, INC.
26%
BlackRock, Inc.
8.9%
VANGUARD GROUP INC
5.5%
Woodline Partners LP
4.2%
FMR LLC
3.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. |
3/4/5
13F
10%+ Owner · Company
|
26%
from 13F
|
$345,672,360
31,424,760 shares
|
— | 18 Feb 2025 |
| BlackRock, Inc. |
13F
Company
|
8.9%
|
$85,306,665
10,867,091 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
5.5%
|
$52,499,230
6,687,800 shares
|
— | 31 Mar 2025 |
| Woodline Partners LP |
13F
Company
|
4.2%
|
$40,249,336
5,127,304 shares
|
— | 31 Mar 2025 |
| FMR LLC |
13F
Company
|
3.6%
|
$34,986,238
4,456,846 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
3%
|
$29,017,360
3,696,479 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
181
Shares
99,735,332
Rows available
181
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
183
Q2 2025 holders
181
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend